GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Oct 2015 09:58 AM
RNS
Total Voting Rights
30 Sep 2015 01:40 PM
RNS
Director/PDMR Shareholding
28 Sep 2015 04:54 PM
RNS
Director/PDMR Shareholding
24 Sep 2015 02:54 PM
RNS
CHMP opinion for mepolizumab (Nucala) in Europe
24 Sep 2015 08:03 AM
RNS
Intention to file Relvar Ellipta for COPD in Japan
23 Sep 2015 08:30 AM
RNS
ViiV Healthcare Phase lllb/IV STRIIVING data
17 Sep 2015 12:13 PM
RNS
Director/PDMR Shareholding
14 Sep 2015 03:52 PM
RNS
Director/PDMR Shareholding
10 Sep 2015 01:06 PM
RNS
Director/PDMR Shareholding
09 Sep 2015 07:00 AM
RNS
Results from the SUMMIT COPD CV Survival Study
01 Sep 2015 09:47 AM
RNS
Total Voting Rights
01 Sep 2015 09:43 AM
RNS
Director/PDMR Shareholding
01 Sep 2015 09:41 AM
RNS
Director/PDMR Shareholding
28 Aug 2015 03:14 PM
RNS
Director/PDMR Shareholding
27 Aug 2015 12:31 PM
RNS
Director/PDMR Shareholding
21 Aug 2015 07:00 AM
RNS
GSK to divest ofatumumab - auto-immune indications
14 Aug 2015 04:49 PM
RNS
Director/PDMR Shareholding
12 Aug 2015 03:32 PM
RNS
Director/PDMR Shareholding
05 Aug 2015 03:41 PM
RNS
Director/PDMR Shareholding
04 Aug 2015 02:25 PM
RNS
Publication of Prospectus
03 Aug 2015 01:39 PM
RNS
Director/PDMR Shareholding
03 Aug 2015 12:19 PM
RNS
Director/PDMR Shareholding
03 Aug 2015 11:57 AM
RNS
Total Voting Rights
31 Jul 2015 05:22 PM
RNS
Adjusted Free Cash Flow Performance Measure
29 Jul 2015 12:00 PM
RNS
Half Yearly Report
27 Jul 2015 02:45 PM
RNS
Director/PDMR Shareholding
27 Jul 2015 09:07 AM
RNS
Director/PDMR Shareholding
24 Jul 2015 05:18 PM
RNS
Director/PDMR Shareholding
24 Jul 2015 05:14 PM
RNS
Director/PDMR Shareholding
24 Jul 2015 05:13 PM
RNS
Director/PDMR Shareholding
24 Jul 2015 05:06 PM
RNS
Director/PDMR Shareholding
21 Jul 2015 03:14 PM
RNS
Director/PDMR Shareholding
20 Jul 2015 12:45 PM
RNS
Director/PDMR Shareholding
20 Jul 2015 12:36 PM
RNS
Director/PDMR Shareholding
20 Jul 2015 12:21 PM
RNS
Director/PDMR Shareholding
10 Jul 2015 04:03 PM
RNS
Director/PDMR Shareholding
10 Jul 2015 03:58 PM
RNS
Director/PDMR Shareholding
10 Jul 2015 03:54 PM
RNS
Director/PDMR Shareholding
10 Jul 2015 01:23 PM
RNS
Director/PDMR Shareholding
07 Jul 2015 12:03 PM
RNS
Director/PDMR Shareholding
01 Jul 2015 03:34 PM
RNS
Director/PDMR Shareholding
01 Jul 2015 01:56 PM
RNS
Director/PDMR Shareholding
01 Jul 2015 10:22 AM
RNS
Total Voting Rights
24 Jun 2015 10:36 AM
RNS
Director/PDMR Shareholding
22 Jun 2015 12:08 PM
RNS
Regulatory update - sale of Nimenrix and Mencevax
12 Jun 2015 07:00 AM
RNS
US FDA Advisory Committee on mepolizumab
11 Jun 2015 07:00 AM
RNS
Blocklisting Application
10 Jun 2015 03:32 PM
RNS
Director/PDMR Shareholding
09 Jun 2015 10:17 AM
RNS
Director/PDMR Shareholding
01 Jun 2015 10:03 AM
RNS
Total Voting Rights

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings